RetinalGenix Technologies Inc.
RTGN
$3.20
-$0.35-9.86%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -13.65% | 10.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.42% | 10.56% | |||
| Operating Income | 12.42% | -10.56% | |||
| Income Before Tax | 12.41% | -10.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 12.41% | -10.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.41% | -10.57% | |||
| EBIT | 12.42% | -10.56% | |||
| EBITDA | 12.42% | -10.57% | |||
| EPS Basic | 13.56% | -11.67% | |||
| Normalized Basic EPS | 13.57% | -11.62% | |||
| EPS Diluted | 13.56% | -11.67% | |||
| Normalized Diluted EPS | 13.57% | -11.62% | |||
| Average Basic Shares Outstanding | 1.38% | -1.06% | |||
| Average Diluted Shares Outstanding | 1.38% | -1.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||